Spyre Therapeutics
Sunrise
About Spyre Therapeutics
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies with the potential to revolutionize the treatment of inflammatory bowel disease (IBD).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $835.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: nasdaq:SYRE
- Website: spyre.com
- Phone: +1 954 838 9625
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/spyre-therapeutics-60466 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.